The DRAGON Trials: Next Generation Liver Cancer Care with Erik Schadde, MD

Erik Schadde, MD, FACS, FEBS (HPB), a transplant surgeon at RUSH University Medical Center, spearheaded the creation of the DRAGON trials - large, multicenter, international trials that are evaluating the use of combined portal and hepatic vein, or double vein, embolization, to treat advanced liver cancer and metastases.

Related Stories